v1
A 12-month, Prospective, Open-label, Phase 4 Study to Evaluate the Efficacy and Safety of OZURDEX® (Dexamethasone Intravitreal Implant) in Treatment Naïve Patients (According to Standard Clinical Practice) With Diabetic Macular Edema
NobleIDNI3P53W21R64S10
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260526/8AF98AC4)
ARK Inflections
Metadata Formats
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims
Paper Authors